Safety and Pharmacokinetic Study of IMM0306 in Patients With Refractory or Relapsed CD20-positive B-cell Non-Hodgkin's Lymphoma (B-NHL)
Clinical trial NCT04746131 · SUSPENDED
Trial details
- NCT number
- NCT04746131
- Sponsor
- ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
- Status
- SUSPENDED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-15
- Primary completion
- 2024-04-11
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.